A drug that targets multiple pathogenic steps in diabetic retinopathy may be an ideal therapeutic strategy for the disease, Vanderbilt researchers report.
According to a new study, the tiny zebrafish may hold the secret to regenerating damaged retinas in humans.
Vanderbilt Eye Institute researchers have discovered that an imbalance in the ionic environment of retinal ganglion cells may contribute to functional impairments in glaucoma.
Paul Sternberg Jr., MD, G.W. Hale Professor of Ophthalmology and Visual Sciences at Vanderbilt and chair of the department, has been named to receive the 2018 Award of Merit in Retina Research Recipient by the Retina Society.
Researchers at Vanderbilt University Medical Center and Vanderbilt University have received a $1.9 million grant from the National Institutes of Health (NIH) to support research to restore vision through regeneration of the retina.
Certain protein factors have been identified as attractive targets for treating diabetic retinopathy, a major cause of blindness in adults.